Mechanisms of Adverse Drug Effects in Children

The summary for the Mechanisms of Adverse Drug Effects in Children grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Mechanisms of Adverse Drug Effects in Children: The major focus of the Program Announcement (PA) is to solicit projects that enhance the state-of-the-science on the molecular and cellular mechanisms involved in the production of adverse drug reactions in children. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. This PA will use the NIH R01 and R21 award mechanisms. Applications may be submitted by domestic or foreign, for-profit or non-profit organizations, public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research i! s invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. There is no limit on the number of scientifically different applications that may be submitted. Applications must be prepared using the PHS 398 research grant application instructions and forms (rev. 9/2004). The PHS 398 is available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email: [email protected]. Telecommunications for the hearing impaired: TTY 301-451-0088.
Federal Grant Title: Mechanisms of Adverse Drug Effects in Children
Federal Agency Name: National Institutes of Health
Grant Categories: Income Security and Social Services Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-05-045
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: National Institute of Child Health and Human Development Extramural Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 03, 2008
Posted Date: Jan 31, 2005
Creation Date: Dec 12, 2006
Archive Date: Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Special district governments Small businesses State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses City or township governments Native American tribal governments (Federally recognized) County governments
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
• Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical...
• Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial No...
• Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P5...
• Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...
• Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
• Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
• Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
• Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
• Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
• Immune Tolerance Network (UM1 Clinical Trial Required)
• Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
• National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
• Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com